Publications by authors named "Emma Rathbone"

Claim this Profile
F
First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study.
Laura Moliner, Núria Zellweger, Sabine Schmid, Martina Bertschinger, Christine Waibel, Emma Rathbone

JTO Clin Res Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged bone health benefits for breast cancer patients following adjuvant bisphosphonate therapy: the BoHFAB study.
Janet Brown, Margaret A Paggiosi, Emma Rathbone, Walter Gregory, Gian Bertelli

J Bone Miner Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results.
Matthew Winter, Rob Coleman, Jessica Kendall, Carlo Palmieri, Chris Twelves, Emma Rathbone

J Bone Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial.
Rob Coleman, Janet Brown, Emma Rathbone, Louise Flanagan, Amber Reid

Trials· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis.
Emma Rathbone, Lindsay Durant, James Kinsella, Antony R Parker, Ghaniah Hassan-Smith

J Neurol Neurosurg Psychiatry· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial.
Janet Brown, Emma Rathbone, Samantha Hinsley, Walter Gregory, Fatma Gossiel

J Natl Cancer Inst· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.
Robert Coleman, David Cameron, David Dodwell, Richard Bell, Caroline Wilson, Emma Rathbone

Lancet Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04).
Emma J Rathbone, Janet E Brown, Helen C Marshall, Michelle Collinson, Victoria Liversedge

J Clin Oncol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of cancer treatment-induced bone loss.
Robert E Coleman, Emma Rathbone, Janet E Brown

Nat Rev Rheumatol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual acuity in young elite motorsport athletes: a preliminary report.
Anthony G Schneiders, S John Sullivan, Emma J Rathbone, A Louise Thayer, Laura M Wallis

Phys Ther Sport· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis